nent when she was standing. As a result, she had difficulties balancing herself standing and had to bear weight on her left heel during the stance phase of walking. With her foot and toes hyperextended, she was only able to take ten steps before complaining of tiredness and severe discomfort on her left heel. She had to sit on a wheelchair to perform ADL that require standing. She also had difficulty performing lower body dressing because the hyperextended foot got in the way when she tried to put on her pants. She was also unable to put on her shoes due to the foot deformity. These complications caused severe disabilities and impaired her independence.
The patient was treated with intramuscular injections of botulinum toxin type A (BTX-A) to the left tibialis anterior, EHL and extensor digitorum longus (EDL) under electromyography guidance followed by a programme of intensive stretching and strengthening exercises. The BTX-A dosages given were 50, 25 and 25 units to each muscle respectively without any complications. One month post-injection, the spasticity decreased a half grade for ankle dorsiflexors (MAS grade 1+) and one grade for toe extensors (MAS grade 2) when examined at rest. When assessed during standing and walking, her spasticity decreased significantly with the left foot achieving plantigrade position. Performing lower body dressing was not as cumbersome as before and she could wear shoes comfortably.
Spasticity is a common complication following spinal cord lesions from traumatic and non-traumatic aetiologies with reported prevalence between 27% and 36% [4, 5] . It normally affects both lower limbs although the clinical patterns of spasticity are more varied in cases of incomplete lesions or incomplete recovery. In our case, the patient developed an uncommon pattern of ankle spasticity: a focal spasticity of unilateral ankle dorsiflexor muscles (tibialis anterior, EHL and EDL) following incomplete recovery of acute transverse myelitis.
Problems have been encountered in patients with ankle spasticity affecting other muscles around the foot such as ankle plantar flexors, invertors or EHL alone [2, 3, 6] . In this case, the ankle dorsiflexor spasticity was causing problems for the patient. Not only did it affect the standing balance, it also reduced her walking tolerance and distance. The discomfort experienced was so severe that it caused her to compensate using a wheelchair to per form certain ADL. Treatment with BTX-A to the ankle dorsiflexors was useful to correct the abnor mal foot posture, and thus achieved improved function.
Despite the occurrence of disabling ankle spasticity, the patient has shown a marked overall recovery in sensory and motor power following treatment with IV methylprednisolone. Controlled studies of acute myelitis treatment are lacking but current expert consensus favours acute treatment with high-dose corticosteroids for a better outcome as observed in this case [7] . In cases with incomplete myelitis and refractory to steroid therapy, treatable causes such as bacterial infection should be suspected to facilitate appropriate treatments [8] .
Spasticity is a common complication after transverse myelitis. However, involvement of unilateral ankle dorsiflexors is uncommon, so its effect on daily function is unknown. The treatment decision to use BTX-A injection relies partly on the pattern of muscle involvement, the spasticity severity and whether it causes problems or offers benefits to patients [9] . BTX-A injection targeting the specific muscles has been reported to reduce spasticity and improve the patient's functional outcome [6, 10] , which is also relevant in this case even though the spasticity presented is uncommon. 
